麻豆淫院

Twelve teams of University of Colorado faculty, researchers and graduate student innovators competed for a combined $1.25 million in startup funding grants in this year鈥檚 Venture Challenge (LVC).

Vitro3D, a CU Boulder startup pioneering volumetric 3D printing for life sciences, just closed its first investment round of $1.3 million. The hard-won vote of confidence from the investment community will allow the promising new venture to pursue ambitious technical advances while continuing to build critical business capacity.

ColdQuanta, a CU Boulder spinout and the global quantum ecosystem leader, announced a $110 million Series B round of funding to continue commercializing the company鈥檚 product portfolio, including quantum computing, quantum algorithms and applications, atomic clocks, sensors and components.

Arpeggio鈥檚 technology isolates a drug鈥檚 effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors. Funding was led by Builders VC and will support ongoing development of Arpeggio鈥檚 drug pipeline as well as its transcription-monitoring technologies.

This year鈥檚 Top Company winners and finalists represent 13 industry categories. Entrants were judged on three criteria: outstanding achievement, financial performance and community involvement. ColdQuanta won in the "Technology, Software & Communications" category.

It's hard to find a physics or chemistry teacher that doesn't use PhET Interactive Simulations, a free online science and math simulations platform founded at CU Boulder in 2002 by Nobel Laureate Carl Wieman. These beautifully designed STEM explorations are loved by students and educators alike.

Keith 鈥淏ang Bang鈥� McCurdy is taking HYPRSKN鈥攖he microscopic skin implants with adaptive, color-changing in-skin pigments developed by Carson Bruns and Jesse Butterfield of CU Boulder's ATLAS Institute鈥攖o the next level with real tattoo ink that you can 鈥渢urn on鈥� or off using different wavelengths of UV and white light.

The merger is addressing pressing needs in quantum research for CU Boulder spinout ColdQuanta鈥攁s well as the quantum industry. Both companies are affiliates of Q-NEXT, a U.S. Department of Energy (DOE) National Quantum Information Science Research Center led by Argonne National Laboratory.

Think Bioscience (鈥淭hink鈥�), a synthetic biology company focused on developing small-molecule therapeutics that target difficult-to-drug proteins, has raised $17M in an oversubscribed Seed round. Think's foundational IP was developed by CEO Jerome Fox's research group at CU Boulder.

鈥淔or the industry, now is the time to solve this problem,鈥� Wil Srubar, an associate professor at CU Boulder and the lead researcher on the project, says in a news release. 鈥淲e believe that we have one of the best solutions, if not the best solution, for the cement and concrete industry to address its carbon problem.鈥�